PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis

PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis

Abstract Background Daily experience tells us that breast cancer can be controlled using standard protocols up to the advent of a relapse. Now new frontiers in precision medicine like liquid biopsy of cell free DNA (cfDNA) give us the possibility to understand cancer evolution and pick up the key mu...

Full description

Bibliographic Details
Main Authors: Maria Palmieri, Margherita Baldassarri, Francesca Fava, Alessandra Fabbiani, Giuseppe Maria Campennì, Maria Antonietta Mencarelli, Rossella Tita, Stefania Marsili, Alessandra Renieri, Elisa Frullanti
Format: Article
Language:English
Published: BMC 2019-10-01
Series:Cancer Cell International
Subjects:
PIK3CA-CDKN2A
cfDNA
Liquid biopsy
Deep-next generation sequencing
Targeted-therapy
Online Access:http://link.springer.com/article/10.1186/s12935-019-0991-y

Internet

http://link.springer.com/article/10.1186/s12935-019-0991-y

Similar Items